KMID : 1035620170050040185
|
|
Allergy Asthma & Respiratory Disease 2017 Volume.5 No. 4 p.185 ~ p.192
|
|
The KAAACI Standardization Committee Report on the procedure and application of fractional exhaled nitric oxide measurement
|
|
Kwon Jae-Woo
Song Woo-Jung Kim Min-Hye Lim Kyung-Hwan Yang Min-Suk Jung Jae-Woo Lee Jeong-Min Suh Dong-In Shin Yoo-Seob Kim Sae-Hoon Kim Sang-Heon Lee Byung-Jae Cho Sang-Heon
|
|
Abstract
|
|
|
Fractional exhaled nitric oxide (FeNO) is a biomarker for type 2 inflammation in the airways, and its measurement has the distinct strengths of being simple, rapid, convenient, and reproducible. Since the discovery of FeNO in the 1990s, its measurement tools have been extensively developed and validated by several researchers. In particular, FeNO showed the potential to support the diagnosis of asthma and eosinophilic bronchitis. Since it has begun to be widely utilized in clinical research areas as well as daily practice, we summarized the standardized diagnostic procedures and suggested the clinical application of FeNO measurement in Korean population.
|
|
KEYWORD
|
|
Nitric oxide, Diagnostic techniques and procedures, Asthma, Reference standards
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|